Gilead Sciences Names Quigley as Senior Vice President of Research Biology
February 19 2020 - 9:22AM
Dow Jones News
By Michael Dabaie
Gilead Sciences Inc. said Wednesday that Michael Quigley joined
the company as senior vice president of research biology.
Mr. Quigley joined the biopharmaceutical company from
Bristol-Myers Squibb, where most recently he was vice president and
head of Tumor Microenvironment Modulation Thematic Research Center
and site head of the Redwood City, Calif., location.
The company also said it named Linda Higgins as senior vice
president and head of external innovation. Ms. Higgins joined
Gilead in 2010, leading a significant expansion of the company's
Biology organization that included the establishment of Biologics
and Biomarker functions, as well as the addition of inflammation,
oncology and immunology discovery groups.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
February 19, 2020 09:07 ET (14:07 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024